ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,625Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 2035

$958K Total Retail Price of All Prescriptions

Rank: 55 out of 2035

539 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 539 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

28% of this provider’s 539 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 13,430 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 749 636 1 1
METOPROLOL TARTRATE 740 626 2 8
AMLODIPINE BESYLATE 639 538 3 6
HYDROCODONE-ACETAMINOPHEN 620 447 S3 4 2
LISINOPRIL 522 409 5 3
FUROSEMIDE 443 406 6 7
LEVOTHYROXINE SODIUM 396 357 7 4
METFORMIN HCL 395 312 8 9
MIRTAZAPINE 336 293 9 46
DONEPEZIL HCL 314 299 10 24
FENTANYL 267 214 S2 11 53
OMEPRAZOLE 259 212 12 5
GABAPENTIN 250 184 13 14
NAMENDA 234 232 14 37
QUETIAPINE FUMARATE 201 143 15 70
ACETAMINOPHEN-CODEINE 193 164 S3 16 52
WARFARIN SODIUM 163 126 17 11
ATORVASTATIN CALCIUM 161 121 18 13
SERTRALINE HCL 157 96 19 23
POTASSIUM CHLORIDE 152 135 20 18
CLOPIDOGREL 149 130 21 30
TRIAMTERENE-HCTZ 148 103 22 35
TRAMADOL HCL 145 122 23 19
LEVETIRACETAM 142 85 24 87
HYDROCHLOROTHIAZIDE 139 100 25 12
HYDRALAZINE HCL 136 101 26 45
CITALOPRAM HBR 132 98 27 20
LOSARTAN POTASSIUM 126 100 28 15
CLONIDINE HCL 123 96 29 61
ISOSORBIDE MONONITRATE ER 123 122 29 32
ATENOLOL 121 107 31 10
METOPROLOL SUCCINATE 117 107 32 16
LANTUS 115 92 33 40
TRAZODONE HCL 113 98 34 50
PLAVIX 112 101 35 49
ALENDRONATE SODIUM 110 107 36 27
BACLOFEN 109 54 37 112
CARVEDILOL 108 105 38 22
RANITIDINE HCL 107 86 39 28
OLANZAPINE 107 67 39 121
GLIPIZIDE 105 87 41 54
LYRICA 105 80 41 89
POLYETHYLENE GLYCOL 3350 103 90 43 48
ESCITALOPRAM OXALATE 101 93 44 77
ALBUTEROL SULFATE 100 92 45 90
CYMBALTA 94 66 46 59
RISPERIDONE 91 77 47 68
OXYBUTYNIN CHLORIDE ER 91 75 47 117
NOVOLIN R 88 69 49 210
LIDODERM 87 75 50 72
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 73 51 110
MEGESTROL ACETATE 85 69 R 52 175
ALLOPURINOL 84 77 53 34
CIPROFLOXACIN HCL 82 62 54 63
AZITHROMYCIN 81 58 55 39
LACTULOSE 79 57 56 96
DIGOXIN 79 77 56 67
TAMSULOSIN HCL 78 68 58 25
NOVOLOG 77 60 59 95
TRAVATAN Z 75 75 60 199
KLOR-CON M20 74 59 61 73
SANTYL 71 64 62 192
DIVALPROEX SODIUM 70 47 63 75
SEROQUEL 68 55 64 153
NIFEDIPINE ER 66 52 65 98
ENOXAPARIN SODIUM 65 61 66 279
PREDNISONE 65 54 66 36
ADVAIR DISKUS 63 58 68 38
LIDOCAINE HCL VISCOUS 60 0 69 438
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 50 70 26
SPIRONOLACTONE 58 48 71 65
PHENYTOIN SODIUM EXTENDED 58 29 71 132
BUMETANIDE 58 58 71 79
CARBIDOPA-LEVODOPA 56 56 74 94
CEPHALEXIN 55 46 75 91
FLUTICASONE PROPIONATE 55 28 75 29
BETAMETHASONE VALERATE 54 48 77 191
JANUVIA 53 27 78 85
CYCLOBENZAPRINE HCL 51 15 R 79 64
BRIMONIDINE TARTRATE 50 49 80 239
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.